Cellectis (CLLS) EPS (Basic) Growth (1y) (2016 - 2026)
Cellectis (CLLS) EPS (Basic) Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-51.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
186.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
104.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-52.19% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-100.01% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
51.44% |
| Date | Value |
|---|
| Mar 31, 2026 |
51.44% |
| Dec 31, 2025 |
-107.54% |
| Sep 30, 2025 |
102.56% |
| Jun 30, 2025 |
-1,318,815,661.21% |
| Mar 31, 2025 |
-338.27% |
| Dec 31, 2024 |
108.70% |
| Sep 30, 2024 |
98.74% |
| Jun 30, 2024 |
97.86% |
| Mar 31, 2024 |
114.95% |
| Dec 31, 2023 |
-15.83% |
| Sep 30, 2023 |
-3,111.40% |
| Jun 30, 2023 |
100.00% |
| Mar 31, 2023 |
-1,035.68% |
| Dec 31, 2022 |
-6.82% |
| Sep 30, 2022 |
23.99% |
| Jun 30, 2022 |
-124,881,942.39% |
| Mar 31, 2022 |
-137.63% |
| Dec 31, 2021 |
42.10% |
| Sep 30, 2021 |
-16.03% |
| Jun 30, 2021 |
-16.21% |
